<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="16724">Gamma-hydroxybutyrate</z:chebi> (<z:chebi fb="0" ids="16724,30830">GHB</z:chebi>) was evaluated as a <z:chebi fb="1" ids="50267">protective agent</z:chebi> in a gerbil model of non-lethal myocardial injury that follows brain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The accumulation of fat droplets in myocardial fibers following <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> was measured by electron microscopic morphometry and expressed as a percentage of the area of the sarcoplasm </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="16724,30830">GHB</z:chebi> treatment significantly reduced the area occupied by <z:chebi fb="23" ids="18059">lipid</z:chebi> droplets compared with that found in saline treated controls measured both 10 hours (p less than .005) and 24 hours (p less than 0.05) after unilateral carotid ligation </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="16724,30830">GHB</z:chebi> did not affect the ischaemic swelling of the brain </plain></SENT>
</text></document>